C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Position in AMGN — Amgen Inc
CIK 1965756
Westlake, OH
Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$565,269
-$126,819 QoQ
Shares Held
1,561
-20.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,091
of 3,140 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors holds $11,231,670 across 7 Drug Manufacturers - General names. AMGN ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,281 | $5,103,510 | |
| 2 | JNJ |
Johnson & Johnson
|
7,826 | $1,987,569 | |
| 3 | LLY |
ELI LILLY & Co
|
1,374 | $1,648,016 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,782 | $871,487 | |
| 5 | PFE |
Pfizer Inc
|
32,587 | $784,694 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,561 | $565,269 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,146 | $271,125 |
All Filings in AMGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $565,269 | 1,561 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $692,088 | 1,967 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $656,256 | 2,005 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $665,145 | 2,357 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $377,491 | 1,352 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $396,291 | 1,272 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $331,794 | 1,273 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $437,561 | 1,358 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $240,274 | 769 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $539,639 | 1,898 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $257,777 | 895 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $257,740 | 959 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $213,361 | 961 | Shares | Sole | 2023-07-21 | |
| 2022-12-31 | $206,697 | 787 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||